AtriCure Inc.  

(Public, NASDAQ:ATRC)   Watch this stock  
Find more results for ATRC
21.46
+0.05 (0.23%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.81 - 21.54
52 week 13.19 - 22.97
Open 21.22
Vol / Avg. 126,355.00/192,054.00
Mkt cap 608.66M
P/E     -
Div/yield     -
EPS -0.63
Shares 28.36M
Beta 0.41
Inst. own 92%
May 20, 2015
AtriCure Inc Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
Apr 29, 2015
Q1 2015 AtriCure Inc Earnings Call - 4:30PM EDT - Add to calendar
Apr 29, 2015
Q1 2015 AtriCure Inc Earnings Release - 4:00PM EDT - Add to calendar
Apr 14, 2015
AtriCure Inc at Needham Healthcare Conference - Webcast
Mar 24, 2015
AtriCure Inc Analyst & Investor Meeting - Webcast
Mar 10, 2015
AtriCure Inc at Barclays Healthcare Conference
Feb 23, 2015
Q4 2014 AtriCure Inc Earnings Call - Webcast
Feb 23, 2015
Q4 2014 AtriCure Inc Earnings Release
Feb 12, 2015
AtriCure Inc at Leerink Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -18.17% -15.09%
Operating margin -16.25% -15.23%
EBITD margin - -10.78%
Return on average assets -13.59% -11.99%
Return on average equity -16.02% -15.80%
Employees 320 -
CDP Score - -

Address

6217 Centre Park Dr
WEST CHESTER, OH 45069-3866
United States - Map
+1-513-7554107 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company develops, manufactures and sells devices designed for the surgical ablation of cardiac tissue for the treatment of atrial fibrillation and systems designed for the exclusion of the left atrial appendage. The Company�s products include AtriCure�s Synergy Ablation System and Related Radio Frequency (RF) Ablation Devices, Estech�s Radio Frequency Ablation Devices, Cryoablation System and AtriClip Gillinov-Cosgrove Left Atrial Appendage (LAA) System (AtriClip system). In addition, the Company also sells enabling technologies including Lumitip dissector, the MicroPace ORLab system and Estech valve surgical devices. The Company sells its products through a direct sales force and through a wholly owned subsidiary, AtriCure Europe B.V. The Company�s other wholly owned subsidiaries include AtriCure, LLC and Endoscopic Technologies, LLC.

Officers and directors

Richard M. Johnston Independent Chairman of the Board
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael H. Carrel President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
M. Andrew Wade CPA Chief Financial Officer, Vice President
Age: 39
Bio & Compensation  - Reuters
Douglas J. Seith Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Andrew L. Lux Ph.D. Senior Vice President - R&D, Operations and QA
Age: 62
Bio & Compensation  - Reuters
Patricia J. Kennedy Vice President, General Manager - International
Age: 53
Bio & Compensation  - Reuters
Michael D. Hooven Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark A. Collar Independent Director
Age: 61
Bio & Compensation  - Reuters
Scott William Drake Independent Director
Age: 46
Bio & Compensation  - Reuters
Elizabeth D. Krell Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters